**Core Concept:** Succinylcholine, a depolarizing muscle relaxant, acts by blocking the voltage-gated chloride channels in neuromuscular junction, leading to a temporary blockade of neuromuscular transmission. Vecuronium is a non-depolarizing neuromuscular blocker that binds to nicotinic receptors and competitively inhibits the acetylcholine binding, thereby preventing neuromuscular transmission.

**Why the Correct Answer is Right:**

In this scenario, the patient is given succinylcholine, a depolarizing muscle relaxant, due to the unavailability of vecuronium, a non-depolarizing muscle relaxant. Succinylcholine works by blocking the voltage-gated chloride channels in the neuromuscular junction, resulting in an acute and reversible blockade of neuromuscular transmission. Since succinylcholine is a depolarizing agent, its effects are temporary and rapidly reversible, lasting only for the duration of the stimulus and typically lasting for 1-2 minutes.

**Why Each Wrong Option is Incorrect:**

A. Vecuronium (non-depolarizing muscle relaxant) is incorrect as it was not used due to unavailability, and succinylcholine is being used instead.
B. While succinylcholine does block the neuromuscular junction, the primary issue in this scenario is not related to its action but rather the administration of excessive dose (640 mg) and the lack of reversal agent (neostigmine).
C. Neostigmine is the specific antidote for succinylcholine, as it acts as a competitive inhibitor of acetylcholinesterase, increasing acetylcholine levels at the neuromuscular junction and reversing the effects of succinylcholine.
D. The temporary nature of succinylcholine's effect is true, but the excessive dose (640 mg) is what leads to the patient's respiratory and motor paralysis, rather than the drug's mechanism of action.

**Clinical Pearl:** In clinical practice, succinylcholine should be administered cautiously, considering factors like body weight, muscle relaxation time, and the availability of reversal agents like neostigmine. Excessive doses may lead to prolonged neuromuscular blockade and potential complications such as hyperkalemia and hyperkalemic cardiac arrest due to potassium ion release from skeletal muscle. It is essential to monitor the patient's response closely during and after administration, and ensure the availability of reversal agents like neostigmine for safe and effective management of a potentially life-threatening hyperkalemia and hyperkalemic cardiac arrest.